Genic

At a glance

Genic filed 17 disclosures in the last 12 months, including 4 5% holder. The most recent key filing was on May 4.

Revenue for 2025 was ₩78.2B, up 56.7% on 2024. Operating margin was 19.1% against 12.1% a year earlier. Debt was 38% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩78.6B and operating profit of ₩13.4B.

The 2025 annual report lists 385 employees with an average tenure of 3.8 years and average pay of ₩40.3M, #1745 of 1,829 listed companies by average pay. Its 4 directors and auditors were paid ₩114M each on average. It paid no cash dividend for 2025. 솔브레인홀딩스(주) and related parties held 34.55% at year end.

From the 2025 annual report

Staff: 385 (66 men, 319 women), of whom 41 on fixed-term contracts. Total pay for the year: ₩15.6B. Directors and auditors: 4, paid ₩534M in total.

No cash dividend was paid for 2025.

Largest shareholder

솔브레인홀딩스(주) holds 34.55%; with 0 related parties the group holds 34.55% of common shares at year end.

Auditor: 삼정회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary